Palmoplantar Pustulosis (PPP): Clinical Trials

1 trial for Palmoplantar Pustulosis (PPP), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Palmoplantar Pustulosis (PPP): new trials by email Literature Review of Palmoplantar Pustulosis (PPP) trials Research Report on Palmoplantar Pustulosis (PPP)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis
Spesolimab, Placebo - Palmoplantar Pustulosis (PPP)
Phase 2CompletedBoehringer Ingelheim1522019-07-312025-10-16

Narrower conditions

Psoriasis (1)

Broader conditions

Skin Diseases (1)  ·  Skin Diseases, Papulosquamous (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

spesolimab (1)

Sponsors

Boehringer Ingelheim (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Russia (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 37731086

NIH funding

2018 (1)